Triethanolamine lauryl sulfate (TEALS) is an anionic surfactant commonly used in personal care products. It is synthesized through the reaction of lauric acid with triethanolamine, forming the lauryl sulfate ester. TEALS acts as a foaming agent, emulsifier, and detergent. It is known to be a mild surfactant, making it suitable for use in products like shampoos, body washes, and facial cleansers. The study of TEALS often focuses on its safety and efficacy as a surfactant, as well as its potential environmental impact. Due to its widespread use in personal care products, research on TEALS examines its potential for skin irritation and sensitization, particularly in individuals with sensitive skin. Additionally, research investigates its biodegradability and environmental persistence, considering its impact on aquatic ecosystems. '
texapon TH: sodium dodecyl sulfate compd. with triethanolamine [1:1] [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 8777 |
| CHEMBL ID | 3187366 |
| SCHEMBL ID | 97773 |
| MeSH ID | M0130455 |
| Synonym |
|---|
| dodecyl hydrogen sulfate - 2,2',2''-nitrilotriethanol (1:1) |
| 139-96-8 |
| maprofix tls 500 |
| laurylsulfuric acid triethanolamine salt |
| triethanolamine monododecyl sulfate |
| tea lauryl sulfate |
| triethanolamine lauryl sulfate |
| sulfuric acid, dodecyl ester, triethanolamine salt |
| propaste t |
| tris(2-hydroxyethyl)ammonium lauryl sulphate |
| standapol t |
| drene |
| emal t |
| standapol tls 40 |
| tylorol lt 50 |
| einecs 205-388-7 |
| sulfuric acid, monododecyl ester, compd with 2,2',2''-nitrilotriethanol (1:1) |
| sulfetal lt |
| cycloryl tawf |
| lauryl sulfate triethanolamine salt |
| richonol t |
| emersal 6434 |
| rewopol tls 40 |
| stepanol wat |
| texapon t-35 |
| texapon t-42 |
| dodecyl sulfate triethanolamine salt |
| elfan 4240 t |
| hsdb 2899 |
| tea-lauryl sulfate |
| melanol lp20t |
| sipon lt-40 |
| sipon lt-6 |
| sulfuric acid, monododecyl ester, compd with 2,2',2''-nitrilotris(ethanol) (1:1) |
| cycloryl wat |
| steinapol tls 40 |
| akyposal tls |
| texapon th |
| triethanolamine dodecyl sulfate |
| sterling wat |
| sipon lt |
| maprofix tls 65 |
| maprofix tls |
| NCGC00256950-01 |
| dtxsid4027076 , |
| tox21_303076 |
| cas-139-96-8 |
| dtxcid207076 |
| ethanol, 2,2',2''-nitrilotris-, dodecyl sulfate (salt) |
| unii-e8458c1kaa |
| e8458c1kaa , |
| tea-lauryl sulfate [vandf] |
| tea-lauryl sulphate |
| trolamine laurylsulfate [who-dd] |
| trolamine laurylsulfate |
| trolamine lauryl sulphate |
| triethanolamine lauryl sulphate |
| tea lauryl sulphate |
| tea-lauryl sulfate [inci] |
| trolamine lauryl sulfate [ii] |
| dodecyl sulfate triethanolamine |
| trolamine lauryl sulfate |
| triethanolamine lauryl sulfate [hsdb] |
| SCHEMBL97773 |
| JZKFHQMONDVVNF-UHFFFAOYSA-N |
| triethanolamine laurylsulfate |
| CHEMBL3187366 |
| triethanolamine lauryl sulfate, aldrichcpr |
| FT-0700868 |
| decahydro-2-naphtholacetate |
| 2,2',2''-nitrilotriethanol dodecyl sulfate |
| Q27276995 |
| 2-[bis(2-hydroxyethyl)amino]ethanol;dodecyl hydrogen sulfate |
| 2,2,2-nitriloethanol lauryl sulfate |
| tris(hydroxyethyl)amine lauryl sulfate |
| trihydroxytriethylamine lauryl sulfate |
| triethanolamine lauryl sulfate 40 % solution in water |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| estrogen receptor 2 (ER beta) | Homo sapiens (human) | Potency | 61.5361 | 0.0006 | 57.9133 | 22,387.1992 | AID1259377; AID1259378 |
| peroxisome proliferator-activated receptor delta | Homo sapiens (human) | Potency | 17.4589 | 0.0010 | 24.5048 | 61.6448 | AID743215; AID743227 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 48.4755 | 0.0578 | 21.1097 | 61.2679 | AID1159526; AID1159528 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 58.5737 | 0.0003 | 23.4451 | 159.6830 | AID743065; AID743067 |
| Cellular tumor antigen p53 | Homo sapiens (human) | Potency | 76.9588 | 0.0023 | 19.5956 | 74.0614 | AID651631 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (47.57) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||